Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223
Revised: May 8, 2014
Accepted: May 25, 2014
Published online: August 14, 2014
Core tip: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and its incidence is rising in Western countries. The choice among therapeutic options that include liver resection, liver transplantation, locoregional, and systemic treatments must be individualized for each patient. The aim of this paper is to review the outcomes that can be achieved in the treatment of HCC with the heterogeneous therapeutic options currently available in clinical practice.